AFFX: AFFYMETRIX INC Profile

Ticker

Advertisement

Choose a Broker

Dynamic view of the market

U.S. Markets open in 15 hrs, 22 mins

Symbol	Value	Change	Percentage Change
DJIA	11,288.54	73.03	0.65%
NASDAQ	2,245.38	-6.08	-0.27%
S&P 500	1,262.90	1.38	0.11%

AFFYMETRIX INC

AFFX

Stock price

9.82 -0.32 -3.16%

as of 01:00 PM EDT on 07/03/2008 in USD (NASDAQ Delay: 15 mins.)
Extended Hours

— — —

Analyst Consensus

Hold
Analyst Consensus

Strong Buy

Buy

Hold

Sell

Strong Sell
- Add to Portfolio
- Add to Alerts
Discuss: AFFX

Insightful information about industries, companies, and the people who lead them.

Learn More.

2007 Sales	2007 Sales Growth	2007 Net Income	2007 Employees
$371,300,000	4.5%	$12,600,000	1,141

Key Executives: AFFX

Name	Title	Officer Since
Stephen P.A. Fodor, Ph.D.	CEO	1/1/93
John C. Batty	CFO	-
James R. Gibson, II	Chief Accounting Officer	-
Kevin M. King	President	-
Barbara A. Caulfield, Esq.	Secretary	-
Dr. Robert H. Trice, Ph.D.	Director	2/15/06
Robert P. Wayman	Director	3/19/07
Dr. John D. Diekman, Ph.D.	Director	1/1/93

View All Key Executives

Kevin M. King has been our President since September 2007. Mr. King joined us in January 2007 as President of Life Sciences Business and Executive Vice President. From February 2005 until June 2006, Mr. King served as President and Chief Executive Office of Thomson Healthcare. From 1997 to 2004, Mr. King held various managerial positions at General Electric-Healthcare, most recently as Vice President and General Manager of Global Clinical Systems... View Full Profile

Kevin M. King

Barbara A. Caulfield, Esq. joined us in July 2001 as Executive Vice President, General Counsel and Secretary. From 1994 until June 2001, Ms. Caulfield was a partner at the law firms of Latham & Watkins and Orrick, Herrington & Sutcliffe. Previously, Ms. Caulfield served as United States District Judge for the Northern District of California from 1991 to 1994. As a partner at Orrick, Herrington & Sutcliffe, Ms. Caulfield represented Affymetrix in... View Full Profile

Barbara A. Caulfield, Esq.

John C. Batty joined us in June 2007 as Executive Vice President and Chief Financial Officer. Mr. Batty served as Senior Vice President of Finance and Chief Financial Officer of Credence Systems Corporation from 2005 to 2007. From 1999 to 2005, Mr. Batty held several management positions with Network Equipment Technologies Inc., a global provider of networking technology platforms, most recently as its Chief Operating Officer from 2001 to 2004.... View Full Profile

John C. Batty

Robert H. Trice, Ph.D., has served as a director since 2006. Dr. Trice has been Senior Vice President for Business Development at Lockheed Martin Corporation since October 1998.... View Full Profile

Dr. Robert H. Trice, Ph.D.

James R. Gibson II joined in August 2002 as Director of Accounting Operations, and was promoted to Vice President, Accounting and Corporate Controller of the Company in January 2006. In December 2006, Mr. Gibson was appointed Principal Accounting Officer and in January 2007 was appointed to serve as the Interim Principal Financial Officer of the Company until the Company completes it search for a new Chief Financial Officer and Principal... View Full Profile

James R. Gibson, II

Robert P. Wayman has served as a director since 2007. Mr. Wayman served as Executive Vice President and Chief Financial Officer of Hewlett-Packard Company ("HP") from 1984 until his retirement in December of 2006. Mr. Wayman also served as Interim Chief Executive Officer of HP from February 2005 through March 2005 and served on the Board of Directors of HP from February 2005 to March 2007 and from 1993 to 2002. Mr. Wayman has served as a director... View Full Profile

Robert P. Wayman

John D. Diekman, Ph.D., has served as a director since 1993. Dr. Diekman has served as a managing partner of 5AM Ventures, a life sciences investment partnership, since August 2002. From June 1998 until July 2002, Dr. Diekman served as a managing director of Bay City Capital, a life sciences merchant bank. Dr. Diekman served as Chairman of the Company from 1993 to August 1999 and served as Vice Chairman from July 1999 to December 1999. Dr.... View Full Profile

Dr. John D. Diekman, Ph.D.

Paul Berg, Ph.D., has served as a director since 1993. Dr. Berg is Cahill Professor of Cancer Research and Biochemistry, Emeritus and Director, Emeritus of the Beckman Center for Molecular and Genetic Medicine at the Stanford University School of Medicine. He received the Nobel Prize in Chemistry in 1980, the National Medal of Science in 1983, and is a member of the National Academy of Sciences, the Royal Society, London, and the French Academy... View Full Profile

Dr. Paul A. Berg, Ph.D.

Stephen P.A. Fodor, Ph.D., is our Founder, Chairman and Chief Executive Officer. Dr. Fodor has served as our director since 1993, Chief Executive Officer since 1997 and Chairman since 1999. At various times between 1993 and 1997, Dr. Fodor served as our President, Chief Operating Officer and Chief Technology Officer. Dr. Fodor was Vice President and Director of Physical Sciences at the Affymax Research Institute from 1989 to 1993. Dr. Fodor is... View Full Profile

Stephen P.A. Fodor, Ph.D.

Vernon R. Loucks, Jr. has served as a director since 1993. Mr. Loucks has served as Chairman of The Aethena Group, LLC, a private equity firm, since January 2001. From January 2003 to November 2003, Mr. Loucks served as Chief Executive Officer of Segway Inc., a company providing solutions to short-distance travel. From February 1998 through December 2000, Mr. Loucks served as Chairman of InLight, Inc. Mr. Loucks served as Chief Executive Officer... View Full Profile

Vernon R. Loucks, Jr.

Susan D. Desmond-Hellmann, M.D., M.P.H., has served as a director since 2004. Dr. Desmond-Hellmann is President, Product Development at Genentech, Inc. Dr. Hellmann joined Genentech in 1995 as a clinical scientist, was named Chief Medical Officer in 1996, and became executive vice president, Development and Product Operations, in 1999.... View Full Profile

Dr. Susan D. Desmond-Hellmann, M.D., M.P.H

John A. Young has served as a director since 1993. Mr. Young retired as President and Chief Executive Officer of Hewlett-Packard Company in October 1992 after a career with the company which began in 1958. He serves as a director of Vermillion, Inc., (formerly Ciphergen Biosystems, Inc.), Fluidigm Corporation, Nanosys, Inc. and Perlegen. He is a member of the National Academy of Engineering. He served as co-chairman of President Clinton's... View Full Profile

John A. Young

Top Competitors: AFFX

View Detailed Competitors Chart

Insider Trends: AFFX
Sentiment for AFFX is POSITIVE
- 0M
- 2M
- 4M
- 6M
- Market Value of Insider Sales
- Market Value of Insider Purchases
Total dollar value of all insider purchases and sales over 12 months
View All Insider Sentiment

Insider Transactions: AFFX

Date	Name	Shares	Transaction Type	Market Value
06/27/08	GIBSON JAMES R II	6,900	Award of Stock Options	$0.00
06/27/08	KING KEVIN M	20,000	Award of Stock Options	$0.00
06/27/08	FODOR STEPHEN P A	25,000	Award of Stock Options	$0.00

View All Insider Activity

Ownership Breakdown : AFFX

Large Block Holder Type	Number
Institutions	211.00
Mutual Fund	360.00
Other Major	13.00

Full Details

Indices : AFFX

Symbol	Name	Last Trade	Change
$RUT.X	Russell 2000 Index	665.78	-6.56 -0.98%
$IDX	S&P 400 Midcap Index	—	——%

View all Indices that include AFFX

Short Interest Volume: AFFX

Data as of 6/10/08

Current Short Interest Shares	1.10 B
Current Short Interest Ratio	7.10
Float	68.81 M

Short Interest as % of Float	19.40
Average Daily Volume	1.86 M
Outstanding Shares	69.42 M

Full Details

SEC Filings: AFFX

Accepted Date	Description
07/03/2008	SEC Filing: Current Event
06/30/2008	SEC Filing: Insider Buy/Sell
06/30/2008	SEC Filing: Insider Buy/Sell

View all SEC Filings

Get Profile Details for:

- Help & Feedback

Market Movers

Related Resources

My Portfolios

AOL Real-Time Streaming Quotes

AFFYMETRIX INC

AFFX

Stock price

9.82 -0.32 -3.16%

as of 01:00 PM EDT on 07/03/2008 in USD (NASDAQ Delay: 15 mins.)
Analyst Consensus
- Strong Buy
- Buy
- Hold
- Sell
- Strong Sell
- Add to Portfolio
- Add to Alerts
Discuss: AFFX

Quote Search Search the Web Search

More in Money & Finance
- Money
- Earnings
- Tech News
- Stock Screener
- Banking
- Checking Account
- Savings Account
- Credit Cards
- Credit Reports
- Identity Theft
- Debt Management
- Loans
- Auto Loan
- Personal Loans
- Mortgages
- Refinancing
- Taxes
- Online Tax Filing
- Tax Advice
- Tax Basics
- Tax Forms
- Audit
- Tax Credit
- Tax Deduction
- AMT
- Small Business
- BloggingStocks
- BloggingBuyouts
- Luxist
- TUAW
- DJIA
- Dow Jones Industrial Average
More Stock Research
Notices and Terms: Confirm all data with your broker before trading.

Quote data provided by Interactive Data. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Financial.

The AFFYMETRIX INC profile at AOL Money & Finance provides you with all the affx investing information you need. Reference AOL Money & Finance before you make your next investment!

© 2008 AOL LLC. All Rights Reserved.

AOL@Money © 2008 AOL LLC. All Rights Reserved.

Live Updates:

Ticker

Dynamic view of the market

AFFYMETRIX INC

AFFX

Stock price

Extended Hours

Analyst Consensus

AFFYMETRIX INC Profile

Key Executives: AFFX

Top Competitors: AFFX

Insider Trends: AFFX

Insider Transactions: AFFX

Ownership Breakdown : AFFX

Indices : AFFX

Short Interest Volume: AFFX

SEC Filings: AFFX

Quote Details

Classic Chart

Advanced Chart BETA

Real-Time Headlines

Message Boards

Profile

Earnings Analysis

Event Calendar

Financials